Advanced search
Publication Cover
Pain Management Volume 2, 2012 - Issue 6
Submit an article Journal homepage
55
Views
0
CrossRef citations to date
0
Altmetric
Management Perspective

An Overview of Treatment Strategies for Cancer Pain with a Focus on Interventional Strategies and Techniques

Amitabh Gulati1 Department of Anesthesiology & Critical Care, Board Certified in Anesthesiology & Pain Management, Memorial Sloan Kettering Cancer Center, M308, New York, NY, 10065, USA.Correspondence[email protected]
,
Jatin Joshi2 Department of Anesthesiology, Weill Medical College, Cornell University, New York, NY, USA
&
Aisha Baqai2 Department of Anesthesiology, Weill Medical College, Cornell University, New York, NY, USA
Pages 569-580 | Published online: 23 Nov 2012

References

  • Jemal A , TiwariRC, MurrayT et al. Cancer statistics, 2004. CA Cancer J. Clin. 54 , 8–29 (2004).
  • Wootton M . Morphine is not the only analgesic in palliative care: literature review. J. Adv. Nurs.45 , 527–532 (2004).
  • Vielhaber A , PortenoyRK. Advances in cancer pain management. Hematol. Oncol. Clin. North Am.16 , 527–541 (2002).
  • Prager J , JacobsM. Evaluation of patients for implantable pain modalities: medical and behavioral assessment. Clin. J. Pain17 , 206–214 (2001).
  • de Leon-Casasola OA . Critical evaluation of chemical neurolysis of the sympathetic axis for cancer pain. Cancer Control7(2) , 142–148 (2000).
  • WHO. Cancer pain relief and palliative care. Report of WHO Expert Committee (3rd Edition). WHO, Geneva, Switzerland (1996).
  • Eisenberg E , ShifrinA. Reassessing the need for Step 2 of the WHO analgesic ladder. J. Pain Palliative Care Pharmacother.25(3) , 288–290 (2011).
  • Pharo GH , ZhouL. Pharmacologic management of cancer pain. J. Am. Osteopathic Assoc.105(5) , S21–S28 (2005).
  • Nabal M , LibradaS, RedondoMJ, PigniA, BrunelliC, CaraceniA. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature. Palliat. Med.26(4) , 305–312 (2012).
  • Caraceni A , HanksG, KaasaS. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol.13(2) , e58–e68 (2012).
  • Vadalouca A , RaptisE, MokaE, ZisP, SykiotiP, SiafakaI. Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature. Pain Pract.12(3) , 219–251 (2012).
  • Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Rodriguez G, Nalamachu S, Langley P. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract. doi:10.1111/j.1533-2500.2012.00578.x (2012) (Epub ahead of print).
  • Brown-Glaberman U , StopeckAT. Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors. Biologics6 , 89–99 (2012).
  • Rodriguez RF , BravoLE, CastroF. Incidence of weak opioids adverse events in the management of cancer pain: a double-blind comparative trial. J. Palliat. Med.10(1) , 56–60 (2007).
  • Leppert W . The role of methadone in cancer pain treatment – a review. Int. J. Clin. Pract.63(7) , 1095–1109 (2009).
  • Maltoni M , ScarpiE, ModonesiC et al. A validation study of the WHO analgesic ladder: a two-step vs three-step strategy. Support Care Cancer 13(11) , 888–894 (2005).
  • McNicol E , StrasselsS, GoudasL, LauJ, CarrD. Nonsteroidal anti-inflammatory drugs, alone or combined with opioids, for cancer pain: a systematic review. J. Clin. Oncol.22(10) , 1975–1992 (2004).
  • Colson J , KoyyalaguntaD, FalcoFJ, ManchikantiL. A systematic review of observational studies on the effectiveness of opioid therapy for cancer pain. Pain Physician14(2) , E85–E102 (2011).
  • Pigni A , BrunelliC, GibbinsJ. Content development for European Guidelines on the use of opioids for cancer pain: a systematic review and Expert Consensus Study. Minerva Anestesiol.76(10) , 833–843 (2010).
  • Krames E . Interventional pain management. Appropriate when less invasive therapies fail to provide adequate analgesia. Med. Clin. North Am.83 , 787–808 (1999).
  • Lema MJ . Invasive analgesia techniques for advanced cancer pain. Surg. Oncol. Clin. North Am.10(1) , 127–136 (2001).
  • Wong GY , SchroederDR, CarnsPE et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 291 , 1092–1099 (2004).
  • Kawamata M , IshitaniK, IshikawaK et al. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain 64 , 597–602 (1996).
  • Polati E , FincoG, GottinL, BassiC, PederzoliP, IschiaS. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br. J. Surg.85 , 199–201 (1998).
  • de Leon-Casasola OA , KentE, LemaMJ. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Pain54(2) , 145–151 (1993).
  • Reisfield GM , WilsonGR. Blocks of the sympathetic axis for visceral pain #97. J. Palliat. Med.7(1) , 75–76 (2004).
  • Petersohn JD . Sympathetic neural blockade. In: Pain Procedures in Clinical Practice. Lennard TA, Walkowski SA, Singla AK, Vivian D et al. (Eds). Elsevier, Philadelphia, PA, USA 507–519 (2011).
  • Christo PJ , MazloomdoostD. Interventional pain treatments for cancer pain. Ann. NY Acad. Sci.1138 , 299–328 (2008).
  • Nabil Abbas D , Abd El Ghafar EM, Ibrahim WA, Omran AF. Fluoroscopic stellate ganglion block for postmastectomy pain: a comparison of the classic anterior approach and the oblique approach. Clin. J. Pain27(3) , 207–213 (2011).
  • Lipov EG , JoshiJR, SandersS et al. Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study. Lancet Oncol. 9(6) , 523–532 (2008).
  • Rathmell JP . Atlas of image-guided intervention in regional anesthesia and pain medicine. Brown B, Murphy F (Eds). Lippincott Williams & Wilkins, PA, USA (2005).
  • Arcidiacono PG , CaloriG, CarraraS, McNicolED, TestoniPA. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst. Rev.16(3) , CD007519 (2011).
  • Yan BM , MyersRP. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am. J. Gastroenterol.102(2) , 430–438 (2007).
  • Kambadakone A , ThabetA, GervaisDA, MuellerPR, ArellanoRS. CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics31(6) , 1599–1621 (2011).
  • Gulati A , KhelemskyY, LohJ. The use of lumbar sympathetic blockade at l4 for management of malignancy-related bladder spasms. Pain Physician14 , 305–310 (2011).
  • Day M . Sympathetic blocks: the evidence. Pain Prac.8(2) , 98–109 (2008).
  • de Oliveira R , dos Reis MP, Prado WA. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain110(1–2) , 400–408 (2004).
  • Mauck WD , RhoRH. The role of neurolytic sympathetic blocks in treating cancer pain. Tech. Reg. Anesth. Pain Manage.14(1) , 32–39 (2010).
  • Bhatnagar S , KhannaS, RoshniS et al. Early ultrasound-guided neurolysis for pain management in gastrointestinal and pelvic malignancies: an observational study in a tertiary care center of urban India. Pain Pract. 12(1) , 23–32 (2012).
  • Krames E . Intraspinal opioid therapy for chronic nonmalignant pain: current practice of clinical guidelines. J. Pain Symptom Manage.11(6) , 333–352 (1996).
  • Hayek SM , PaigeB, GirgisG et al. Tunneled epidural catheter infections in noncancer pain: increased risk in patients with neuropathic pain/complex regional pain syndrome. Clin. J. Pain 22(1) , 82–89 (2006).
  • Smith TJ , CoynePJ. Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients. J. Palliat. Med.8(4) , 736–742 (2005).
  • Mercadante S , IntravaiaG, VillariP et al. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin. J. Pain 23(9) , 793–798 (2007).
  • Candido K , StevensRA. Intrathecal neurolytic blocks for the relief of cancer pain. Best Pract. Res. Clin. Anaesthesiol.17(3) , 407–428 (2003).
  • Hurlow A , BennettMI, RobbKA, JohnsonMI, SimpsonKH, OxberrySG. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database Syst. Rev.3 , CD006276 (2012).
  • Flagg A 2nd, McGreevy K. Williams K. Spinal cord stimulation in the treatment of cancer-related pain: “back to the origins”. Curr. Pain Headache Rep.16(4) , 343–349 (2012).
  • Yakovlev AE , ReschBE. Spinal cord stimulation for cancer-related low back pain. Am. J. Hosp. Palliat. Care29(2) , 93–97 (2012).
  • Interventional pain management (2nd Edition). Waldman SD (Ed.). Saunders Elsevier, PA, USA (2001).
  • Jeon YS , LeeJA, ChoiJW et al. Efficacy of epidural analgesia in patients with cancer pain: a retrospective observational study. Yonsei Med. J. 53(3) , 649–653 (2012).
  • Miguel R . Interventional treatment of cancer pain: the fourth step in the world health organization analgesic ladder. Cancer Control7(2) , 149–156 (2000).
  • Slatkin NE , RhinerM. Phenol saddle blocks for intractable pain at end of life: report of four cases and literature review. Am. J. Hosp. Palliat. Care20(1) , 62–66 (2003).
  • Gilmer-Hill HS , BogganJE, SmithKA et al. Intrathecal morphine delivered via subcutaneous pump for intractable cancer pain: a review of the literature. Surg. Neurol. 51(1) , 12–15 (1999).
  • Upadhyay SP , MallickPN. Intrathecal drug delivery system for cancer pain management: a review and updates. Am. J. Hospice Palliat. Med.29(5) , 388–398 (2012).
  • de Leon-Casasola OA . Interventional procedures for cancer pain management: when are they indicated? Cancer Invest.22(4) , 630–642 (2004).
  • Smith TJ , StaatsPS, DeerT et al; Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J. Clin. Oncol.20(19) , 4040–4049 (2002).
  • Jang I , ShinIW, OkSH et al. Spinal anesthesia and intrathecal clonidine decrease the hypnotic requirement of propofol. Reg. Anesth. Pain Med. 35(2) , 145–147 (2010).
  • Watve SV , SivanM, RazaWA, JamilFF. Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord50(2) , 107–111 (2012).
  • Wallace MS , RauckR, FisherR et al. Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial. Anesth. Analg. 106(2) , 628–637 (2008).
  • Deer TR , PragerJ, LevyR et al. Polyanalgesic Consensus Conference-2012: recommendations on trialing for intrathecal (intraspinal) drug delivery: report of an Interdisciplinary Expert Panel. Neuromodulation 15(5) , 420–435 (2012).
  • Deer TR , PragerJ, LevyR et al. Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an Interdisciplinary Expert Panel. Neuromodulation 15(5) , 436–466 (2012).
  • Brogan SE , WinterNB. Patient-controlled intrathecal analgesia for the management of breakthrough cancer pain: a retrospective review and commentary. Pain Med.12(12) , 1758–1768 (2011).
  • Miller D , FentonD, DionJ. Vertebroplasty. In: Image-Guided Spine Intervention. Fenton D (Ed.). Saunders, Philadelphia, PA, USA, 189–223 (2003).
  • Maynard AS , JensenME, SchweickertPA, MarxWF, ShortJG, KallmesDF. Value of bone scan imaging in predicting pain relief from percutaneous vertebroplasty in osteoporotic vertebral fractures. AJNR Am. J. Neuroradiol.21 , 1807–1812 (2000).
  • O‘Brien JP , SimsJT, EvansAJ. Vertebroplasty in patients with severe vertebral compression fractures: a technical report. AJNR Am. J. Neuroradiol.21(8) , 1555–1558 (2000).
  • Buchbinder R , OsborneRH, EbelingPR et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N. Engl. J. Med. 361(6) , 557–568 (2009).
  • Kallmes DF , ComstockBA, HeagertyPJ et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N. Engl. J. Med. 361 , 569–579 (2009).
  • Kobayashi T , AraiY, TakeuchiY et al. Phase I/II clinical study of percutaneous vertebroplasty (PVP) as palliation for painful malignant vertebral compression fractures (PMVCF): JIVROSG-0202. Ann. Oncol. 20 , 1943–1947 (2009).
  • Pflugmacher R , TaylorR, AgarwalA et al. Balloon kyphoplasty in the treatment of metastatic disease of the spine: a 2-year prospective evaluation. Eur. Spine J. 17 , 1042–1048 (2008).
  • Berenson J , PflugmacherR, JarzemP et al. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncol. 12 , 225–235 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.